Search

everythinglearnresearchcommunity

for

Search:↓

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

The EMG-to-force model accurately predicts hip muscle forces during walking.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Possible link between androgens and COVID-19 severity; more research needed.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Finasteride may increase stroke risk in people with clotting tendencies.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Baricitinib is effective and safe for treating severe alopecia areata.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.